Silicon Valley Bank

Silicon Valley Bank, established in 1983, is a leading commercial bank headquartered in Santa Clara, California. It specializes in providing a wide array of financial services, including banking, treasury management, and international banking, to innovative technology, life science, and premium wine businesses, as well as venture capital and private equity firms. With a global presence through 27 U.S. offices and seven international operations, the bank leverages its industry knowledge, connections, and world-class service to support the success of its clients.

Trefor Bacon

Director

Greg Becker

CEO

Julie Betts

Managing Director

Gerald Brady

Managing Director, SVB Network

Jayson Davis

Managing Director

Brian Foley

Managing Director

Craig Fox

Managing Director - Fintech

Rob Freelen

Head of Venture Capital Relationship Management

Peter Freyer

Managing Director of National Healthcare Sponsor Finance and Life Sciences

Matt Garrity

Senior Vice President

Rob Helm

Managing Director

Dale Kirkland

Managing Director - Origination / Relationship Management

Scott McCarty

Director, Life Sciences

Andrew Merget

Managing Director

Christopher Morrison

Managing Director and Head of Boston Enterprise Software

Andrew Oddo

Managing Director, Startup Banking

Andrew Parker

Director

Joan Parsons

Executive Vice President, Corporate Banking

Sameer Paul

Director

Marisa Phan

Managing Director - Enterprise Software

Priya Rajan

Managing Director - India and Middle East and North Africa

Vera Shokina

Managing Director

Peter Sletteland

Associate

Ben Tickler

Managing Director - Enterprise Software

Andrew Tsao

Managing Director. Founder / Head of Global Gateway

Jordy Samiljan

Managing Director, I Leveraged Finance and Sponsor Coverage

John Benetti

Managing Director

Past deals in North Carolina

Chimerix

Post in 2024
Chimerix, Inc. is a biopharmaceutical company based in Durham, North Carolina, focused on the development of innovative medicines for patients with cancer and serious viral infections. The company is advancing several clinical-stage programs, including dociparstat sodium (DSTAT), a glycosaminoglycan compound aimed at improving outcomes for patients with acute myeloid leukemia during chemotherapy. Another key candidate is brincidofovir (BCV), an antiviral drug being developed as a medical countermeasure for smallpox. Chimerix also leads the development of CMX001, a broad-spectrum antiviral agent targeting life-threatening double-stranded DNA viral infections, currently undergoing multiple clinical studies for use in immunocompromised patients. Additionally, CMX157, an antiviral compound with activity against HIV and hepatitis B, is in development, addressing challenges posed by existing therapies. The company collaborates with various organizations for research and commercialization, deriving revenue from licensing agreements and royalties. Founded in 2000, Chimerix is committed to transforming patient care through its advanced therapeutic candidates.

Pryon

Debt Financing in 2022
Pryon Inc. is an artificial intelligence company based in Raleigh, North Carolina, that focuses on enhancing enterprise knowledge management. Founded in 2017 by Igor Jablokov, Pryon develops an augmented intelligence platform that combines human and machine capabilities to streamline access to information across various channels and sources. The platform employs natural language processing and automated machine learning to transform unstructured data into actionable insights, thereby boosting productivity and decision-making accuracy. By utilizing a no-code approach, Pryon enables organizations to quickly harness the value of their information assets without disrupting existing operations. The company's solutions aim to simplify AI adoption, reduce complexity, and lower costs for businesses seeking to improve their workflows and knowledge utilization.

Troy Medicare

Debt Financing in 2022
Troy Medicare is a pharmacy-powered Medicare Advantage company established in 2019 and headquartered in Charlotte, North Carolina. The company focuses on delivering personalized Medicare health plans, utilizing data and technology to enhance access to fair and transparent healthcare options. By collaborating with pharmacies and healthcare providers, Troy Medicare aims to significantly improve patient health outcomes and incentivize providers based on these results. The company's approach emphasizes individual needs, ensuring that members receive tailored support to navigate their healthcare journey effectively.

Humacyte

Debt Financing in 2021
Humacyte, Inc. is a medical research and development company based in Morrisville, North Carolina, focused on creating and commercializing human tissue-based products for regenerative medicine and vascular surgery. The company specializes in designing acellular extracellular matrices, which are crafted in vitro from banked vascular smooth muscle cells and decellularized to prevent rejection. These products serve as tissue-engineered grafts for patients requiring vascular repair or replacement. Humacyte's innovative approach aims to provide universally implantable bioengineered human tissues and organs, addressing various diseases, injuries, and chronic conditions while enhancing patient care and transforming medical practices. Founded in 2004, the company is committed to advancing solutions for vascular diseases and the replacement of anatomical conduits.

Nasuni

Debt Financing in 2020
Nasuni Corporation is a provider of enterprise cloud file storage solutions, designed to address the challenges associated with the growth of unstructured file data. Founded in 2009 and headquartered in Boston, Massachusetts, with additional offices in the United Kingdom and North Carolina, Nasuni offers its proprietary Nasuni UniFS, a cloud-native global file system that consolidates and protects file data in an easily expandable cloud infrastructure. This platform serves as a modern replacement for traditional network-attached storage and file server systems, simplifying IT administration by eliminating the need for complex legacy backup and disaster recovery solutions. Nasuni’s services cater to various industries, including architecture, engineering, healthcare, manufacturing, and financial services, enabling organizations to efficiently store, share, and access their files from anywhere, whether in the office or remotely.

Clinical Ink

Debt Financing in 2018
Clinical Ink, Inc. specializes in providing eSource and patient engagement solutions designed to streamline clinical research for sites, sponsors, contract research organizations (CROs), and patients. Founded in 2006 and headquartered in Horsham, Pennsylvania, with additional offices in Winston-Salem and Cary, North Carolina, Philadelphia, Pennsylvania, and Cambridge, Massachusetts, the company offers a suite of innovative tools including SureSource, an electronic source platform that captures data and documents at the site level, and Lunexis ePRO+, which facilitates patient participation in studies. Additionally, Clinical Ink provides CentrosHealth, a patient engagement platform that includes configurable apps to enhance patient involvement and compliance throughout clinical trials. The company aims to improve clinical trial workflows by integrating electronic data capture and reducing manual processes, ensuring that clients have access to high-quality, validated data.

Intarcia Therapeutics

Debt Financing in 2016
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

Samanage

Series B in 2015
Samanage Ltd. is a cloud-based service management platform that empowers organizations to enhance employee productivity through streamlined IT management solutions. Established in 2007 and headquartered in Cary, North Carolina, Samanage offers a range of services, including IT service management, IT service desk, and technology audits. Its software simplifies complex tasks and automates basic functions, facilitating faster and more efficient service delivery across various sectors, particularly healthcare and financial services. In 2019, Samanage became a subsidiary of SolarWinds Corporation, further expanding its capabilities and reach. The company's focus on delivering insights and improving service experiences has positioned it as a leading provider in the service management industry.

Appia

Debt Financing in 2013
Appia is a prominent mobile user acquisition network that specializes in delivering mobile app downloads to over 1 billion users across 200 countries. The company provides a marketplace platform for mobile application developers, offering them a distribution point while enabling advertisers to acquire high-value customers. Appia's advanced technology and extensive network ensure that applications reach a large and engaged audience, maximizing app installs and profit per install for its clients. With a diverse portfolio of trusted brands, Appia has established itself as a leader in mobile app discovery. The company operates from offices in San Francisco, California, and Durham, North Carolina, along with global sales offices, and has gained recognition for its rapid growth and innovation in the mobile advertising space.

Argos Therapeutics

Debt Financing in 2007
Argos Therapeutics, Inc. was a biotechnology company based in Durham, North Carolina, focused on developing personalized immunotherapies for cancer, infectious diseases, and autoimmune disorders. It utilized its proprietary Arcelis technology platform to create individualized treatments, including rocapuldencel-T, which was undergoing Phase III clinical trials for metastatic renal cell carcinoma, and AGS-004, in Phase II trials for human immunodeficiency virus. The company's product pipeline also included therapies aimed at transplant rejection and autoimmune conditions. Founded in 1997 and originally named Merix Bioscience, Argos Therapeutics aimed to address significant unmet medical needs in the field of immuno-oncology. However, on September 24, 2019, the company filed for Chapter 7 bankruptcy, leading to its cessation of operations.

Intarcia Therapeutics

Debt Financing in 2005
Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions requiring long-term treatment. The company is known for its innovative drug delivery platform, DUROS, which stabilizes and administers therapeutic proteins and peptides effectively. Among its key products is ITCA 650, currently in phase 3 clinical trials for type 2 diabetes, designed to provide patients with continuous dosing of an incretin mimetic therapy. Intarcia also explores treatments for obesity and other chronic disorders. Established in 1995 and headquartered in Boston, Massachusetts, Intarcia operates a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina. The company was previously known as BioMedicines, Inc. before adopting its current name in 2004.

Catena Networks

Series D in 2002
Catena Networks develops broadband access systems that enable service providers to deploy voice, data, and video services. The company's products include The CNX-5 Broadband DSL System, a card-for-card upgrade solution for Lucent SLC-5 Digital Loop Carriers and The CN1000 Broadband Loop Carrier that enables service providers to deploy integrated plain old telephone service (POTS) and digital subscriber line (DSL) services and deliver voice, data and video services over copper and fiber infrastructures. It caters to local exchange carriers, postal telephone and telegraph operators, and other service providers. The company was founded in 1998 and is based in California, US with an additional office in Morrisville, North Carolina.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.